Clariscan 0.5 mmol/mL solution for injection

Qualitative and Quantitative Composition:
Each mL; contains 279.3 mg gadoteric acid* (in the form of gadoterate meglumine) equivalent to 0.5 mmol as active ingredient and tetraxetan (DOTA) 202.46 mg and gadolinium oxide 90.62 mg as excipient.
*Gadoteric acid: complex of 1,4,7,10 tetraazacyclododecane N,N’,N””,N””‘ tetraacetic acid (tetraxetan (DOTA)) with gadolinium Macrocyclic, Gadolinium-based MRI contrast agent

Commercial presentations:
1x10mL Vial
1x15mL Vial
1x20mL Vial